Euronovis Srl

What Euronovis Srl does

Euronovis Srl is an Italian B2B contract manufacturer (CMO) specializing in coating, granulation, and pelletization services for the nutraceutical and dietary supplement industry. Headquartered in Liscate near Milan, the company operates an approximately 1,000-1,500 sqm ISO 8 GMP-certified cleanroom facility with annual coating capacity exceeding 800 million tablets and granulation capacity of 100 tons. Its technology stack is built around Nicomac high-shear mixers and fluid bed dryers for wet granulation, Caleva extruders and spheronizers for pelletization, and pharmaceutical-grade coating equipment for film and sugar coating, all governed by PLC-PC automated control systems compliant with CFR 21 Part 11.

The company serves third-party nutraceutical, pharmaceutical, and life science manufacturers that require specialized solid oral dosage processing capabilities without investing in in-house equipment. Service lines include functional coatings (color matching, modified release, protection and taste masking), wet granulation, extrusion/spheronization pelletization, plus formulation R&D, technology transfer, and professional training delivered at its dedicated academy facility. Euronovis claims Italian market leadership in coating for food supplements and positions itself among leading European players, supported by GMP certification since 2019 and FSSC 22000 V.6 certification achieved in 2025.

Commercially, Euronovis runs a direct B2B sales motion targeting enterprise nutraceutical and contract-manufacturing clients across Europe, with quote-based, project-driven pricing tied to batch size and service complexity. The company was acquired in October 2023 by Stockholm-based Wellma Group, a European network of nutraceutical and niche pharmaceutical companies, gaining cross-border distribution, capital, and integration with sister entities. Post-acquisition activity — cleanroom expansion (2023-2024), pelletization service launch (2023), FSSC 22000 certification (2025), and the KSM-66 Ashwagandha pellet co-development with Ixoreal Biomed — points to an active scaling phase.

Name

Euronovis Srl

Legal name

Euronovis Srl

Website

https://euronovis.eu

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Euronovis Srl is an Italian B2B contract manufacturer providing pharmaceutical-grade coating, granulation, and pelletization services for nutraceutical and dietary supplement companies, operating an ISO 8 GMP-certified facility near Milan and serving 40+ clients as part of Wellma Group.

Ownership category

akta.pro rank

Product category

Contract Manufacturing Services

akta.pro primary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

akta.pro secondary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

• Contract manufacturing services
• Nutraceutical coating
• Pharmaceutical granulation
• Pellet production
• Food supplement manufacturing

Headquarters

HQ city

Liscate

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Third-party manufacturing for coating, granulation, and pelletization of nutraceuticals and food supplements. Revenue generated through production service fees based on batch processing and material volumes.
2. Consulting and R&D Services: Formulation development, technology consulting, and technology transfer services. Includes support for regulatory compliance and product optimization.
3. Training Services: Professional training services for pharmaceutical, nutraceutical and food industry companies using Euronovis facilities and expertise.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Euronovis Srl is a B2B contract manufacturer (CMO) providing coating (film and sugar), wet granulation, and pelletization (extrusion/spheronization and powder layering) services for solid oral dosage forms of nutraceutical and food supplement products. The company operates an ISO 8 GMP-certified cleanroom facility near Milan and supports clients from formulation development through industrial-scale production, including color matching, modified-release coating, protection/masking coating, technology transfer, and professional training.

Product overview

Euronovis Srl operates as a contract manufacturing organization (CMO) specialized in coating, granulation, and pelletization of nutraceutical and dietary supplement products. The portfolio is organized around three core production services: Coating Services (film coating and sugar coating, including color matching, modified release, and protection/masking sub-services), Granulation Services (wet granulation via High Shear Mixer and fluid bed dryer), and Pelletization Services (extrusion/spheronization and powder layering). These are supported by consulting services (formulation development, R&D), technology transfer, and professional training. A notable product formulation is the KSM-66 Ashwagandha Pellet developed with Ixoreal Biomed. The company operates as a single unified service offering rather than a modular software platform, providing end-to-end contract manufacturing for the life science industry.

Differentiator

Problem solved

Functional benefit

Products and services

• Coating Services Third-party coating (film coating and sugar coating) services for nutraceutical solid oral dosage forms, using polymeric films or sugar-based solutions for aesthetic, protective, and functional purposes, with sub-capabilities for color matching, modified-release coating, and protection/masking.
• Granulation Services Wet granulation third-party services using High Shear Mixer (NICOMIX 75-200, 50-100 kg capacity) and fluid bed dryer (NICOBED 120, 50-100 kg capacity) to transform fine powders into homogeneous granules for nutraceutical production.
• Pelletization Services Nutraceutical pellet production via extrusion/spheronization and powder layering technologies, producing uniform spherical pellets (500-1,500 microns) for controlled-release dosage forms.
• Formulation Development & R&D Consulting Consulting services supporting formulation development for nutraceutical clients, from raw material selection and particle characterization to process optimization and industrial scale-up.
• Technology Transfer Competency transfer service enabling nutraceutical companies to independently operate coating, granulation, and pelletization technologies, including hands-on training and on-site support.
• Training Services

Quantifiable outcome

• 800 million+ tablets coated per year
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core, major and supporting.

• NicomaccoreTechnology or IntegrationNicomac is a leading manufacturer of coating and granulation equipment (bombola coating machines, fluid bed dryers, high shear mixers). Euronovis was originally founded as a Nicomac showroom in 2010 before becoming independent in 2015. The partnership continues with immediate maintenance support agreements ensuring minimal production downtime.
• CalevacoreTechnology or IntegrationCaleva provides extruders and spheronizers used in Euronovis pelletization processes. These machines enable production of uniform, spherical pellets for controlled release formulations.
• Ixoreal BiomedmajorStrategic or Co-development PartnerEuronovis collaborates with Ixoreal Biomed, producer of KSM-66 Ashwagandha, to develop innovative pellet formulations using extrusion and spheronization technology. This partnership combines Ixoreal's high-quality Ashwagandha extract with Euronovis's pharmaceutical-grade pelletization capabilities.
• Universities and Research InstitutessupportingStrategic or Co-development PartnerEuronovis collaborates with universities and accredited research institutes for R&D activities, raw material studies, and continuous innovation in coating, granulation and pelletization technologies. The company also hosts students for thesis projects.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Lonza: Global CDMO with pharmaceutical manufacturing services including solid dose and coating capabilities, primarily focused on biologics. Broad incumbent comparable in contract manufacturing business model and pharma-grade standards.
• Thermo Fisher Scientific (Patheon): Global pharma services and CDMO division offering comprehensive contract manufacturing for small molecules and biologics. Broad incumbent providing pharma-grade manufacturing services at global scale.
• Catalent: Global pharmaceutical CDMO offering broad contract manufacturing, formulation, and coating services across many dosage forms. Broad incumbent with overlapping solid-dose capabilities though much larger scale and broader portfolio than Euronovis.
• Eurofins CDMO: European CDMO with contract development and manufacturing services for pharma and biopharma customers, including solid dose manufacturing. Broad incumbent overlapping in European CDMO contract manufacturing services.

Direct peers

• Delpharm: European pharmaceutical contract manufacturer offering solid oral dose manufacturing across multiple European sites. Comparable in CDMO service model and customer overlap in the pharma/nutraceutical border zone.
• NextPharma: European pharmaceutical CMO specializing in solid, semi-solid, and liquid dosage forms for pharma and health products. Comparable to Euronovis in serving nutraceutical and life science customers with contract manufacturing and formulation services.
• Aenova Group: One of Europe's largest pharmaceutical contract manufacturers offering solid dosage form services (coating, granulation, pelletization) across multiple sites. Directly comparable to Euronovis in service portfolio and European CDMO positioning, though materially larger in scale.
• Recipharm: Swedish-headquartered pharmaceutical CDMO with a pan-European manufacturing footprint offering solid dose formulation, coating, and granulation services. Geographically and strategically aligned with Euronovis via shared Swedish ownership context and similar B2B contract manufacturing model.
• Fareva: French-headquartered European CMO providing contract manufacturing for pharma, cosmetics, and home care. Comparable B2B contract manufacturing model serving life science customers, including solid dose manufacturing.
• Glatt Group: German equipment manufacturer and process technology provider for fluid bed granulation, coating, and pelletization — directly overlapping Euronovis's core process technology domains, including contract manufacturing services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/euronovis-srl

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Euronovis Srl